Regulus Therapeutics | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Celldex Therapeutics USD 17.14M 11.22M 2025-03
Cipla INR 8B 1.22B 2025-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 18.23M 11.01M 2024-12
CSL 1.52B 133M 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Grifols EUR 979.78M 334.84M 2024-12
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ligand Pharmaceuticals USD 256.89M 184.58M 2025-03
Merck USD 8.63B 4.61B 2025-03
Sanofi 7.44B 646M 2024-12
Takeda JPY 385.11B 109.01B 2025-03



Regulus Therapeutics Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.